Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review
Background Many studies reported high prevalence of antiphospholipid antibodies (aPL) in patients with COVID-19 raising questions about its true prevalence and its clinical impact on the disease course.Methods We conducted a meta-analysis and a systematic review to examine the prevalence of aPL and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-08-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/7/2/e001580.full |